Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Diabet Med. 2015 Jan 7;32(5):657–664. doi: 10.1111/dme.12664

FIGURE 4.

FIGURE 4

Effect of treatment with placebo or muraglitazar on expression of genes involved in free fatty acid oxidation. The dashed line indicates no change in gene expression. *P < 0.05 versus pretreatment. †P < 0.05 for the comparison between muraglitazar and placebo therapy-treated groups. Data as means ± se. ACADM, acyl-CoA dehydrogenase; CPT1b, carnitine palmitoyltransferase 1B; CREB1, cAMP-responsive element binding protein 1; HADH, hydroxyacyl-CoA dehydrogenase; IDH3B, isocitrate dehydrogenase 3 (NAD+) beta.